# OMEPRAZOLE MAGNESIUM
> **ANDA210593** · Abbreviated New Drug Application (Generic) · Sponsor: SPIL · Approved 2018-07-20
## Drug
- **FDA Application Number:** ANDA210593
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OMEPRAZOLE MAGNESIUM
- **Generic name:** OMEPRAZOLE
- **Active ingredients:** OMEPRAZOLE MAGNESIUM
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SPIL
- **Manufacturer:** INNOVUS PHARMACEUTICALS, INC.
- **First approval:** 2018-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210593)
---
*MORVS · CC0 1.0*